Prostate cancer patients undergoing radical prostatectomy increased by double digits while those undergoing brachytherapy decreased.
Racial differences in prostate cancer (PCa) treatment regret more pronounced among those without sexual problems.
But overall risk of heart-related death risk from prostate cancer treatment is small, researchers say.
Men who have slept with more than 20 female partners are less likely to develop aggressive prostate cancer (PCa).
Patients who smoke during external beam radiotherapy (EBRT) are at increased risk of distant metastases and dying from prostate cancer.
Consuming ten portions of tomatoes a week can lower the risk of prostate cancer.
Significant association observed for high-risk prostate cancers with no difference according to daily dose.
Vitamin D may be able to suppress inflammation in prostate tissue by boosting expression of the GDF-15 gene.
Fathering of dizygotic twins, a marker of high fertility, was not associated with increased risk of prostate cancer.
New data confirms that ConfirmMDx, an epigenetic assay, is able to accurately identify prostate cancer aggressiveness
Testosterone replacement therapy (TRT) may promote prostate cancer tumor growth.
Abnormal triglyceride levels found to increase the post-radical prostatectomy risk of biochemical relapse by 35%.
Findings suggest that normalization of blood fats may reduce risk of prostate cancer.
Mortality was greater with external beam radiotherapy across treatment-specific nomograms for predicting biochemical recurrence.
Researchers confident in this approach because candidates for active surveillance are a heavily screened population.
A biomarker present on the KLK3 gene can predict which GS7 prostate cancer patients will be more aggressive.